Connect with us

Health

Expert says Saskatchewan should consider more targeted vaccine plan as variants surge – moosejawtoday.com

Published

 on


SASKATOON — Nazeem Muhajarine says he feels a sense of relief after receiving his first dose of a COVID-19 vaccine last week at a centre in Saskatoon.

“It was just so well-organized and run. I felt completely safe,” Muhajarine said in an interview.

The professor of community health and epidemiology at the University of Saskatchewan said the province is making great strides quickly getting shots into arms, but he’s concerned some people are being left behind.

Premier Scott Moe touted during question period Wednesday that Saskatchewan is leading the country when it comes to administering first vaccinations. 

“Our way through this pandemic, everyone’s plan to get through this pandemic, is to get everyone vaccinated as quickly as possible,” Moe said. 

More than 365,000 doses of vaccine have been given in Saskatchewan. Health officials say 52 per cent of residents over the age of 40 have received their first shot. 

It puts Saskatchewan — with a population of just under 1.18 million — ahead of other provinces when it comes to doses delivered per capita. Data from a COVID-19 vaccination tracker, run by University of Saskatchewan students using federal and provincial data, suggests the province in outpacing Ontario and Quebec.

Moe credits his Saskatchewan Party’s “robust vaccination plan,” which he says will be augmented in the coming days. Eligibility for all vaccines is being lowered to 44 on Thursday, except for in the north where it will go down to 40. It’s expected to drop to 40 for the general population by Wednesday.

Muhajarine said there’s much to applaud about the vaccine rollout. The choice, initially, to use age-based eligibility meant it was easy to understand and targeted those who were more likely to experience severe outcomes if infected, he said. 

Drive-thru COVID-19 vaccination clinics have also been successful, said Muhajarine. One providing mass immunizations in Regina as the capital has became a hot spot for variants has expecially worked well.

Muhajarine said his own experience shows that organization at larger mass vaccination sites is also commendable. 

However, the professor said now that vulnerable senior populations are immunized and there are highly contagious new strains, the province may be missing the mark.

Getting the most vaccinations out fastest is just part of a good public health response, he said, but surging infections and hospitalizations mean the response should now be targeted to those most affected.

“Workplace spreads and outbreaks have been quite prevalent,” Muhajarine said. “That’s been a huge contributor in Regina and has been a contributor in Saskatoon as well.”

There were 231 new cases in Saskatchewan on Wednesday and four more deaths, including a person in their 30s another in their 40s. The others were over 70. There were 185 people in hospital and 49 in intensive care.

Provincial public health orders were tightened recently as officials warned the more transmissible variant strains were becoming dominant. 

Muhajarine said the recent deaths of influential Cree teacher Victor Thunderchild, 55, in Prince Albert and well-known chef Warren Montgomery, 42, in Regina are examples of people in high-risk work environments who weren’t able to get vaccinations under the age-eligibility plan. 

He said Saskatchewan should consider following Ontario and Manitoba, which are pivoting vaccination plans to target neighbourhoods where people have a higher risk of contracting the virus. 

It should also consider socio-economic factors, including how many residents are in a household and the type of jobs people have, he added.

One example would be neighbourhoods with multi-generational households and where many people work service jobs facing the public. Congregate living facilities such as shelters and correctional centres would be another, he said.

Muhajarine said teachers and other essential workers should also get priority.

Every region in the country is seeing benefits to targeting areas and occupations where the pandemic’s third wave has taken hold, he suggested

“That is not something to be trivialized in this kind of complex and mass undertaking.”

This report by The Canadian Press was first published April 21, 2021. 

— By Kelly Geraldine Malone in Winnipeg

The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada allows Pfizer COVID-19 vaccine for children aged 12-15

Published

 on

(Corrects headline and lead to make clear that Canada was not the first nation as stated by Canadian officials, adds context from Pfizer in fourth paragraph)

By David Ljunggren

OTTAWA (Reuters) –Canada is authorizing the use of Pfizer Inc’s COVID-19 vaccine for use in children aged 12 to 15, the first doses to be allowed in the country for people that young, the federal health ministry said on Wednesday.

Supriya Sharma, a senior adviser at the Canadian federal health ministry, said the Pfizer vaccine, produced with German partner BioNTech SE, was safe and effective in the younger age group.

“We are starting to see the light at the end of the tunnel,” she told reporters.

Sharma and a health ministry spokesman said Canada was the first country to grant such an approval, but a Canadian representative for Pfizer later said Algeria permitted use of the vaccine for this age group in April. The Canadian health ministry said it had no information about the discrepancy.

The U.S. Food and Drug Administration is expected to take a similar step “very soon,” U.S. health officials said.

Separately, authorities reported the third death of a Canadian from a rare blood clot condition after receiving AstraZeneca PLC’s’s COVID-19 vaccine. The man, who was in his sixties, lived in the Atlantic province of New Brunswick.

Jennifer Russell, the chief medical officer of health in New Brunswick, said the province would continue using the AstraZeneca vaccine. Alberta reported a death from clotting on Tuesday and Quebec announced one on April 27.

“There will be rare cases where thrombosis will occur. However, the risks remain minimal compared to the risks, complications and potential consequences of COVID-19,” Russell told reporters.

Canada‘s federal government has bought tens of millions of doses of vaccines but critics complain the pace of inoculation is lagging due to bottlenecks in the 10 provinces, which are responsible for administering the doses.

Alberta will become the first province to offer COVID-19 vaccines to everyone aged 12 and over from May 10, Premier Jason Kenney said on Wednesday, a day after he introduced tighter public health measures to combat a third wave of the pandemic.

Alberta, home to Canada‘s oil patch, has the highest rate per capita of COVID-19 in the country, with nearly 24,000 active cases and 150 people in intensive care.

Around 20% of the 1,249,950 cases of COVID-19 in Canada have been reported in people under the age of 19. Canada has recorded 24,396 deaths.

(Additional reporting by Allison Martell in Toronto and Nia Williams in Calgary;Editing by Chizu Nomiyama and Sonya Hepinstall)

Continue Reading

Health

Younger people filling up COVID-19 intensive care

Published

 on

By Anthony Boadle

BRASILIA (Reuters) –COVID-19 infections continue to spread fast across the Americas as a result of relaxed prevention measures and intensive care units are filling up with younger people, the director of the Pan American Health Organization (PAHO) said on Wednesday.

In Brazil, mortality rates have doubled among those younger than 39, quadrupled among those in their 40s and tripled for those in their 50s since December, Carissa Etienne said.

Hospitalization rates among those under 39 years have increased by more than 70% in Chile and in some areas of the United States more people in their 20s are now being hospitalized for COVID-19 than people in their 70s.

“Despite all we learned about this virus in a year, our control efforts are not as strict, and prevention is not as efficient,” Etienne said in a virtual briefing from Washington.

“We are seeing what happens when these measures are relaxed: COVID spreads, cases mount, our health systems become overwhelmed and people die,” she said.

Canada continues to report significant jumps in infections in highly populated provinces such as Ontario as well as in less populated territories of the North and Yukon, home to remote and indigenous communities, according to PAHO.

Puerto Rico and Cuba remain significant drivers of COVID-19 cases in the Caribbean, which is facing a new surge of the virus, PAHO directors said.

Cases are rapidly accelerating in the Guyanas and across Argentina and Colombia, where weekly case counts are five times higher today than they were this time last year and hospitals are reaching capacity in large Colombian cities.

In Central America, Guatemala is seeing significant spikes in cases and Costa Rica is reporting record-high infections.

While vaccines are being rolled out as fast as possible, they are not a short-term solution because they are in short supply, said Etienne, the World Health Organization’s regional director.

(Reporting by Anthony Boadle; Editing by Nick Macfie)

Continue Reading

Health

Alberta confirms first death linked to AstraZeneca vaccine

Published

 on

Reuters) -The province of Alberta reported its first death of a patient from a rare blood clot condition after receiving the AstraZeneca COVID-19 vaccine, its chief medical officer said.

Canada has reported at least five cases of blood clots following immunization with the vaccine, but public health officials maintain the benefits of the AstraZeneca shot outweigh the potential risks.

The Alberta case, of a woman in her 50s, marks the second case of blood clots, and the only death after more than 253,000 doses of AstraZeneca were administered in the province, Alberta’s chief medical officer of health Dr. Deena Hinshaw said in a statement on Tuesday.

“While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine,” Hinshaw said.

AstraZeneca did not immediately respond to Reuters’ request for a comment.

Canada has had 1,243,242 confirmed coronavirus cases and 24,342 deaths, according to a Reuters tally

Last month, the province of Quebec reported Canada’s first death of a patient after receiving the AstraZeneca COVID-19 vaccine.

AstraZeneca, working with the vaccine’s inventor Oxford University, was one of the leaders in the global race to develop a COVID-19 vaccine. Its cheap and easily transportable shot was hailed as a milestone in the fight against the crisis, but has since faced a series of setbacks.

The rare complication, which some regulators including Health Canada are calling Vaccine-Induced Prothrombotic Immune Thrombocytopenia, involves blood clots accompanied by a low count of platelets, cells in the blood that help it to clot.

Dozens of countries paused the use of the AstraZeneca vaccine in March after reports of rare, but serious, blood clots. Several of them have now resumed use either fully or with restricions after health regulators said the benefits of the shot outweigh any risks.

(Reporting by Vishwadha Chander and Sabahatjahan Contractor in Bengaluru, Editing by Sherry Jacob-Phillips and Angus MacSwan)

Continue Reading

Trending